Search - tctmd.com

Displaying 1 - 20 of 1699

Sort: Relevancy | Date

Presentation Miami Valves 2025

Latest Clinical Update: Silara MiBridge

Presenter: Adrian Ebner

January 30, 2025

Presentation Miami Valves 2025

Clinical Trials for Mitral Regurgitation Beyond TEER: Where to Next

Presenter: Jeffrey Popma

January 30, 2025

Presentation Miami Valves 2025

Clinical Trials Propel TAVR Forward

Presenter: Jeffrey Popma

January 30, 2025

Presentation TCT 2024

ACURATE IDE Insights: Optimizing Clinical Implants

Presenter: NULL

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

Presenter: Seun Alli

October 30, 2024

Presentation TCT 2024

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Presenter: David Wood

October 30, 2024

Presentation TCT 2024

TCT 801: Clinical Impact of Sex Differences and Procedural Setting in Transcatheter Aortic Valve Implantation

Presenter: Henrique Ribeiro

October 30, 2024

Presentation TCT 2024

TCT 960: The Impact of Prior Coronary Artery Bypass Graft Surgery on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison

Presenter: Luis Gruberg

October 30, 2024

Presentation TCT 2024

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Presenter: Allan Schwartz

October 30, 2024

Advertisement

Latest Clinical Update: Silara MiBridge

Clinical Trials for Mitral Regurgitation Beyond TEER: Where to Next

Clinical Trials Propel TAVR Forward

ACURATE IDE Insights: Optimizing Clinical Implants

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Left Atrial Appendage Closure with a Novel Fluoropolymer-Coated Device: The HEAL-LAA Post-Approval Clinical Study

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

TCT 801: Clinical Impact of Sex Differences and Procedural Setting in Transcatheter Aortic Valve Implantation

TCT 960: The Impact of Prior Coronary Artery Bypass Graft Surgery on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content